Which of the following should be assessed during the administration of mucolytic agents?

Question

1. Breathing pattern and rate
2. Monitoring peak flow changes
3. Patient's reaction to treatment
4. Monitoring for presence of hydrogen sulfide (a rotten egg odor), which means that the acetyl-cysteine (Mucomyst) is no longer active
a. 1 and 3 only
b. 1, 2, and 3 only
c. 2, 3, and 4 only
d. 1, 2, 3, and 4

Answer 1

ANS: B
During treatment and short term:
? Instruct and then verify correct use of aerosol nebulization system, including cleaning.
? Assess therapy based on indication for drug: mucolysis and improved clearance of secretions.
? Monitor airflow changes or adverse effects such as a decrease in FEV1.
? Assess breathing pattern and rate.
? Assess patient's subjective reaction to treatment (changes in breathing effort or pattern).
? Discontinue therapy if patient experiences adverse reactions.